Junshi Biosciences Announces the Acceptance of the Supplemental New Drug Application for Toripalimab Combined with Bevacizumab for the First-Line Treatment of Advanced Hepatocellular Carcinoma 18-07-2024, 10:38

VCI Global Completes Sagtec Global Limited’s Nasdaq IPO, Earning US$5.7 Million in Advisory Revenue 7-03-2025, 23:22

HVAC Insulation Market is Projected to Reach USD 6.78 15-02-2023, 17:37